Literature DB >> 8605110

A case-control study of cryptorchidism and maternal hormone concentrations in early pregnancy.

T J Key1, D Bull, P Ansell, A R Brett, G M Clark, J W Moore, C E Chilvers, M C Pike.   

Abstract

Serum samples taken between 6 and 20 weeks of gestation were obtained from 28 mothers who gave birth to cryptorchid sons (cases) and from 108 control mothers. In comparison with controls the cases had 10% higher geometric mean oestradiol (95% CI -13% to +39%: P=0.42) and 10% lower geometric mean testosterone (95% CI -27% to +10%: P=0.30). Among the samples collected between 6 and 14 weeks of gestation geometric mean concentrations of oestradiol and testosterone were 5% lower (95% CI -32% to +31%: P=0.74) and 25% lower (95% CI -45% to +1%: P=0.06) respectively in cases than in controls. Among the samples collected between 15 and 20 weeks of gestation geometric mean concentrations of oestradiol and testosterone were 29% higher (95% CI -8% to +79%: P=0.14) and 21% higher (95% CI -8% to +60%: P=0.18) respectively in cases than in controls. The results do not support the hypothesis that cryptorchidism may be caused by high concentrations of oestradiol in the maternal blood during the first phase of testicular descent, but suggest that the possible association of cryptorchidism with low maternal testosterone during early gestation should be further investigated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605110      PMCID: PMC2074338          DOI: 10.1038/bjc.1996.121

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  The incidence of incomplete descent of the testicle at birth.

Authors:  C G SCORER
Journal:  Arch Dis Child       Date:  1956-06       Impact factor: 3.791

2.  Maternal and gestational factors affecting the risk of cryptorchidism and inguinal hernia.

Authors:  R H Depue
Journal:  Int J Epidemiol       Date:  1984-09       Impact factor: 7.196

3.  A biphasic model for the hormonal control of testicular descent.

Authors:  J M Hutson
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

4.  Risk factors for cancer of the testis in young men.

Authors:  B E Henderson; B Benton; J Jing; M C Yu; M C Pike
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

5.  Cigarette smoking in pregnancy results in marked decrease in maternal hCG and oestradiol levels.

Authors:  L Bernstein; M C Pike; R A Lobo; R H Depue; R K Ross; B E Henderson
Journal:  Br J Obstet Gynaecol       Date:  1989-01

6.  Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences.

Authors:  L Bernstein; R H Depue; R K Ross; H L Judd; M C Pike; B E Henderson
Journal:  J Natl Cancer Inst       Date:  1986-06       Impact factor: 13.506

Review 7.  Undescended testis: the effect of treatment on subsequent risk of subfertility and malignancy.

Authors:  C Chilvers; N E Dudley; M H Gough; M B Jackson; M C Pike
Journal:  J Pediatr Surg       Date:  1986-08       Impact factor: 2.545

8.  Maternal hormone levels in early gestation of cryptorchid males: a case-control study.

Authors:  L Bernstein; M C Pike; R H Depue; R K Ross; J W Moore; B E Henderson
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

9.  The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring.

Authors:  B E Henderson; L Bernstein; R K Ross; R H Depue; H L Judd
Journal:  Br J Cancer       Date:  1988-02       Impact factor: 7.640

10.  The effect of in utero ethinyl oestradiol exposure on the risk of cryptorchid testis and testicular teratoma in mice.

Authors:  A H Walker; L Bernstein; D W Warren; N E Warner; X Zheng; B E Henderson
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

View more
  8 in total

1.  Ex-premature infant boys with hypospadias are similar in size to age-matched, ex-premature infant boys without hypospadias.

Authors:  Michael H Hsieh; David G Alonzo; Edmond T Gonzales; Eric A Jones; Lars J Cisek; David R Roth
Journal:  J Pediatr Urol       Date:  2010-09-15       Impact factor: 1.830

Review 2.  Risk factors for cryptorchidism.

Authors:  Jason K Gurney; Katherine A McGlynn; James Stanley; Tony Merriman; Virginia Signal; Caroline Shaw; Richard Edwards; Lorenzo Richiardi; John Hutson; Diana Sarfati
Journal:  Nat Rev Urol       Date:  2017-06-27       Impact factor: 14.432

Review 3.  Maternal body mass index and risk of testicular cancer in male offspring: a systematic review and meta-analysis.

Authors:  Shama S Alam; Marie M Cantwell; Chris R Cardwell; Michael B Cook; Liam J Murray
Journal:  Cancer Epidemiol       Date:  2010-08-26       Impact factor: 2.984

Review 4.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 5.  Critical windows of exposure for children's health: the reproductive system in animals and humans.

Authors:  J L Pryor; C Hughes; W Foster; B F Hales; B Robaire
Journal:  Environ Health Perspect       Date:  2000-06       Impact factor: 9.031

6.  Testicular cancer risk and maternal parity: a population-based cohort study.

Authors:  T Westergaard; P K Andersen; J B Pedersen; M Frisch; J H Olsen; M Melbye
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

Review 7.  Testicular dysgenesis syndrome and the estrogen hypothesis: a quantitative meta-analysis.

Authors:  Olwenn V Martin; Tassos Shialis; John N Lester; Mark D Scrimshaw; Alan R Boobis; Nikolaos Voulvoulis
Journal:  Environ Health Perspect       Date:  2008-02       Impact factor: 9.031

8.  Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study.

Authors:  Julie R Palmer; Arthur L Herbst; Kenneth L Noller; Deborah A Boggs; Rebecca Troisi; Linda Titus-Ernstoff; Elizabeth E Hatch; Lauren A Wise; William C Strohsnitter; Robert N Hoover
Journal:  Environ Health       Date:  2009-08-18       Impact factor: 5.984

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.